racemetirosine has been researched along with Hyperprolactinemia in 5 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
Hyperprolactinemia: Increased levels of PROLACTIN in the BLOOD, which may be associated with AMENORRHEA and GALACTORRHEA. Relatively common etiologies include PROLACTINOMA, medication effect, KIDNEY FAILURE, granulomatous diseases of the PITUITARY GLAND, and disorders which interfere with the hypothalamic inhibition of prolactin release. Ectopic (non-pituitary) production of prolactin may also occur. (From Joynt, Clinical Neurology, 1992, Ch36, pp77-8)
| Excerpt | Relevance | Reference |
|---|---|---|
| "A study of the effect of alpha-methyl-1-tryosine (metyrosine) blockade (2 g/d for 2 d) of dopamine (DA) synthesis on the PRL and TSH response to domperidone (DOM) and TRH in normal women and subjects with pathological hyperprolactinaemia is reported." | 3.67 | Prolactin and TSH responses to both domperidone and TRH in normal and hyperprolactinaemic women after dopamine synthesis blockade. ( Camanni, F; Ghigo, E; Goffi, S; Massara, F; Molinatti, GM, 1985) |
| "Chronic hyperprolactinaemia was induced by neonatal administration of testosterone or oestradiol and acute hyperprolactinaemia was induced either by administration of alpha-methyl-p-tyrosine (an inhibitor of tyrosine hydroxylase) or by ether exposure." | 1.30 | Effects of N-methyl-D-aspartic acid and kainic acid on prolactin secretion in hyper- and hypoprolactinaemic conditions. ( Aguilar, E; Aguilar, R; Pinilla, L; Tena-Sempere, M, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnson, MP | 1 |
| Chamberlain, M | 1 |
| Pinilla, L | 1 |
| Tena-Sempere, M | 1 |
| Aguilar, R | 1 |
| Aguilar, E | 1 |
| Nicoletti, I | 1 |
| Filipponi, P | 1 |
| Fedeli, L | 1 |
| Ambrosi, F | 1 |
| Giammartino, C | 1 |
| Spinozzi, F | 1 |
| Santeusanio, F | 1 |
| Silverman, WF | 1 |
| Walsh, RJ | 1 |
| Ghigo, E | 1 |
| Goffi, S | 1 |
| Molinatti, GM | 1 |
| Camanni, F | 1 |
| Massara, F | 1 |
5 other studies available for racemetirosine and Hyperprolactinemia
| Article | Year |
|---|---|
Modulation of stress-induced and stimulated hyperprolactinemia with the group II metabotropic glutamate receptor selective agonist, LY379268.
Topics: alpha-Methyltyrosine; Amino Acids; Amphetamine; Amphetamines; Animals; Bridged Bicyclo Compounds, He | 2002 |
Effects of N-methyl-D-aspartic acid and kainic acid on prolactin secretion in hyper- and hypoprolactinaemic conditions.
Topics: alpha-Methyltyrosine; Animals; Animals, Newborn; Enzyme Inhibitors; Estradiol; Female; Hyperprolacti | 1998 |
Catecholamines and pituitary function. IV. Effects of low-dose dopamine infusion and long-term bromocriptine treatment on the abnormal thyrotroph (TSH) dynamics in patients with pathological hyperprolactinaemia.
Topics: alpha-Methyltyrosine; Bromocriptine; Catecholamines; Dopamine; Dose-Response Relationship, Drug; Fem | 1986 |
Prolactin causes increased turnover of dopamine in 10-day-old rat median eminence.
Topics: alpha-Methyltyrosine; Animals; Animals, Newborn; Dopamine; Hyperprolactinemia; Median Eminence; Meth | 1987 |
Prolactin and TSH responses to both domperidone and TRH in normal and hyperprolactinaemic women after dopamine synthesis blockade.
Topics: Adult; alpha-Methyltyrosine; Domperidone; Dopamine; Female; Humans; Hyperprolactinemia; Methyltyrosi | 1985 |